	Circulating tumor DNA methylation markers for the early diagnosis of hepatocellular carcinoma. Clin Exp Med Lu CY, Tsai KF, Yen CJ, Hsieh CJ, Peng PJ, Huang SC, Chuang MR, Chu CJ. PMID: 40085315 [PubMed - indexed for MEDLINE]
	Elevated platelet distribution width and diabetes may serve as preoperative predictors of microvascular invasion in primary hepatocellular carcinoma. J Cancer Res Clin Oncol Wang L, Jun L, Jian'an J, Chunmei R, Yuhuan J, Peng L, Huiming L. PMID: 40085250 [PubMed - indexed for MEDLINE]
	Deep Learning Radiopathomics Models Based on Contrast-enhanced MRI and Pathologic Imaging for Predicting Vessels Encapsulating Tumor Clusters and Prognosis in Hepatocellular Carcinoma. Radiol Imaging Cancer Yu Y, Cao L, Shen B, Du M, Gu W, Gu C, Fan Y, Shi C, Wu Q, Zhang T, Zhu M, Wang X, Hu C. PMID: 40084948 [PubMed - indexed for MEDLINE]
	Transarterial chemoembolization versus hepatic arterial infusion chemotherapy as first treatment for hepatocellular carcinoma with macrovascular invasion. Int J Med Sci He B, Deng M, Li S, Mei J, Lu L, Zuo Z, Guo R, Wei W. PMID: 40084258 [PubMed - indexed for MEDLINE]
	Regulated Cell Death in Lenvatinib Resistance of Hepatocellular Carcinoma: from Molecular Mechanisms to Therapeutic Strategies. Int J Biol Sci Chen R, Hu X, Huang Y, Jiang Y, Chen G, Shan Q, Xu X, Zheng S. PMID: 40083703 [PubMed - indexed for MEDLINE]
	A real-world study of the efficacy of second-line treatment of unresectable hepatocellular carcinoma with esophagogastric varices after progression on first-line lenvatinib combined with PD-1 inhibitor. World J Surg Oncol Li S, Wen Q, Huang W, Qiu Z, Feng L, Yi F. PMID: 40082982 [PubMed - indexed for MEDLINE]
	Clinical value of systemic immunoinflammatory index in predicting recurrence and metastasis in patients with primary liver cancer. BMC Gastroenterol Deng Y, Chen Z, He Q, Wu B, Su T, Mao C, Hu R. PMID: 40082749 [PubMed - indexed for MEDLINE]
	Development and validation of a dynamic prognostic nomogram for conditional survival in hepatocellular carcinoma: an analysis from the Korea Liver Cancer Registry. Sci Rep Kwon JH, Jwa EK, Lee JW, Tak E, Hwang S. PMID: 40082572 [PubMed - indexed for MEDLINE]
	Circulating Immune Features Synergizing Neutrophil-to-Lymphocyte Ratio in Prediction of Poor Survival of Early-Stage Hepatocellular Carcinoma After Thermal Ablation. Technol Cancer Res Treat Fan F, Dong G, Han C, Luo Y, Li X, Dong X, Wang Z, Liang P, Yu J. PMID: 40079761 [PubMed - indexed for MEDLINE]
	Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database. Oncologist Levi A, Blais E, Davelaar J, Ebia MI, Minasyan A, Nikravesh N, Gresham G, Zheng L, Chuy JW, Shroff RT, Wadlow RC, DeArbeloa P, Matrisian LM, Petricoin E, Pishvaian MJ, Gong J, Hendifar AE, Osipov A. PMID: 40079530 [PubMed - indexed for MEDLINE]
	Low-Level Viremia Impairs Efficacy of Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma. Liver Int Li R, Li W, Yang Q, Guan Y, Chen Y, Zhu P, Su K, Li Q, Hu X, Zang M, Zhao M, Zhong M, Yan J, Yang K, Zhu W, Lin Z, Yuan G, Chen J. PMID: 40078069 [PubMed - indexed for MEDLINE]
	Enhanced Anti-Tumor Effects of Natural Killer Cell-Derived Exosomes Through Doxorubicin Delivery to Hepatocellular Carcinoma Cells: Cytotoxicity and Apoptosis Study. Int J Mol Sci Choi YH, Kim HY, Park JO, Choi E. PMID: 40076856 [PubMed - indexed for MEDLINE]
	Deciphering Colorectal Cancer-Hepatocyte Interactions: A Multiomics Platform for Interrogation of Metabolic Crosstalk in the Liver-Tumor Microenvironment. Int J Mol Sci Nelson AB, Reese LE, Rono E, Queathem ED, Qiu Y, McCluskey BM, Crampton A, Conniff E, Cummins K, Boytim E, Dansou S, Hwang J, Safo SE, Puchalska P, Wood DK, Schwertfeger KL, Crawford PA. PMID: 40076609 [PubMed - indexed for MEDLINE]
	Diagnostic Performance of Radiolabelled FAPI Versus [(18)F]FDG PET Imaging in Hepato-Pancreato-Biliary Oncology: A Systematic Review and Meta-Analysis. Int J Mol Sci Henrar RB, Vuijk FA, Burchell GL, van Dieren S, de Geus-Oei LF, Kazemier G, Vahrmeijer AL, Oprea-Lager DE, Swijnenburg RJ. PMID: 40076605 [PubMed - indexed for MEDLINE]
	Advances in Immunotherapy in Hepatocellular Carcinoma. Int J Mol Sci Bloom M, Podder S, Dang H, Lin D. PMID: 40076561 [PubMed - indexed for MEDLINE]
	Radioresistance in Hepatocellular Carcinoma: Biological Bases and Therapeutic Implications. Int J Mol Sci Wu J, Zhao X, Ren B, Duan X, Sun J. PMID: 40076465 [PubMed - indexed for MEDLINE]
	Advances in multi-omics studies of microvascular invasion in hepatocellular carcinoma. Eur J Med Res Wang L, Xu HX, Wang R, Zhang F, Deng D, Zhu X, Tan Q, Yang H. PMID: 40075448 [PubMed - indexed for MEDLINE]
	Multi-omics analysis revealed the novel role of NQO1 in microenvironment, prognosis and immunotherapy of hepatocellular carcinoma. Sci Rep Tang Y, Hu H, Chen S, Hao B, Xu X, Zhu H, Zhan W, Zhang T, Hu H, Chen G. PMID: 40074806 [PubMed - indexed for MEDLINE]
	Integrated analysis and experimental validation reveal the prognostic and immunological features associated with coagulation in hepatocellular carcinoma. Sci Rep Qu G, Liu K, Xu W, Li D. PMID: 40074769 [PubMed - indexed for MEDLINE]
	Association of occupational physical activity and sedentary behaviour with the risk of hepatocellular carcinoma: a case-control study based on the Inpatient Clinico-Occupational Database of Rosai Hospital Group. BMJ Open Nakazawa S, Fukai K, Sano K, Furuya Y, Hoshi K, Kojimahara N, Toyota A, Korenaga M, Tatemichi M. PMID: 40074261 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 71087

Page 1 of 3555



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy